2026 Methods Summit
Valuing Innovation: Measuring What Matters
Moving Beyond Cost-Effectiveness to the Full Spectrum of Patient-Centered Value
March 25, 2026 - Washington, DC
The 7th Annual Methods Summit convenes leaders in value research, policy, and patient advocacy to examine how value assessment can better reflect the full spectrum of what matters to patients, moving beyond traditional cost-effectiveness toward more inclusive, patient-centered approaches.
Agenda
Wednesday, March 25, 2026
9:00 AM || Registration
10:00 AM || Welcome and Fireside Chat
The Summit begins with a welcome message, followed by a fireside chat with the keynote speaker. Discussion will center around the evolution of value definitions and the potential for new methods beyond traditional cost-effectiveness research.
10:40 AM || Session 1: Impacts on Families
This session explores how caregiver impacts, family well-being, and household productivity influence the true value of treatment. Speakers will examine research progress, data limitations, and the importance of integrating family and caregiver impacts into value-based decision-making.
11:30 AM || Break
11:40 AM || Session 2: Severity of Disease
This session will examine how and whether severity of disease can be more systematically embedded in value assessment. Speakers will discuss new methods in this area that may help to align valuation with societal preferences and advance more equitable decision-making.
12:30 PM || Lunch
1:30 PM || Session 3: Innovation and Technology Transfer
This session focuses on “scientific spillover,” highlighting the ripple effects of research, innovation, and technological advancement that extend beyond individual treatments. Panelists will explore how breakthroughs, such as cell and gene therapy and personalized medicine, challenge existing value assessment methods and underscore the importance of capturing their wider societal benefits.
2:20 PM || Closing Panel: Expanding Value: What's Ready, What's Emerging, What's Next
This closing session will discuss whether these and other novel value elements are “ready for prime time” and use in HTA. Panelists will reflect on how patient-centered value research should continue to evolve, guided by insights represented in today’s sessions. The discussion will synthesize key themes from across the day, highlight areas of consensus and continued debate, identify where methodological innovation is most needed, and outline collective next steps.
3:30 PM || Reception
Informal networking and refreshments to close the day.
DETAILS
When:
Wednesday, March 25, 2026
9:00 AM – 5:00 PM EDT
Where:
USC Capital Campus
1771 N Street NW
Washington, DC 20036
(In-Person and Live Stream)